|
Mar 21
|
Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address
|
|
Mar 18
|
Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England
|
|
Mar 16
|
We Think Co-Diagnostics (NASDAQ:CODX) Needs To Drive Business Growth Carefully
|
|
Mar 16
|
Co-Diagnostics Full Year 2023 Earnings: Misses Expectations
|
|
Mar 15
|
Co-Diagnostics, Inc. (NASDAQ:CODX) Q4 2023 Earnings Call Transcript
|
|
Mar 15
|
Q4 2023 Co-Diagnostics Inc Earnings Call
|
|
Mar 14
|
Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
|
|
Mar 7
|
Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test
|
|
Dec 27
|
Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro
|
|
Nov 29
|
Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023
|
|
Nov 10
|
Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2023 Earnings Call Transcript
|
|
Nov 10
|
Q3 2023 Co-Diagnostics Inc Earnings Call
|
|
Nov 9
|
Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results
|
|
Nov 2
|
Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development
|
|
Sep 22
|
Co-Diagnostics, Inc. to Participate in 6th ACTC Conference in Skiathos, Greece
|
|
Sep 21
|
Co-Diagnostics, Inc. to Participate in Gilmartin Group Annual Emerging Growth Showcase on Sept 21
|
|
Sep 7
|
Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 25th Annual Global Investment Conference on September 11-13, 2023
|
|
Aug 11
|
Q2 2023 Co-Diagnostics Inc Earnings Call
|
|
Aug 10
|
Co-Diagnostics, Inc. (CODX) Reports Q2 Loss, Lags Revenue Estimates
|
|
Aug 10
|
Co-Diagnostics, Inc. Reports Second Quarter 2023 Financial Results
|